SCHEMBL19685830

SCHEMBL19685830

Cc1cn(-c2ccccc2)c(=O)c2cc(-n3c4ccc(N(c5ccccc5)c5ccccc5)cc4c4cc(N(c5ccccc5)c5ccccc5)ccc43)ccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.34
SCN2B O60939 1/20 0.34
SCN1A P35498 1/20 0.34
SCN1B Q07699 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN9A Q15858 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 2/20 0.33
HPGD P15428 2/20 0.33
MAPK8 P45983 1/20 0.33
ESR1 P03372 1/20 0.33
ESRRA P11474 1/20 0.33
ESR2 Q92731 1/20 0.33
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.32
MAPT P10636 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19686344 0.96 ESR1 (0.36) APPSCN2BSCN1ASCN1BSCN5A
SCHEMBL19686045 0.89 KDM4E (0.39) APPSCN2BSCN1ASCN1BSCN5A
SCHEMBL19686028 0.88 APP (0.35) APPSMN1; SMN2LMNAHTTHPGD
SCHEMBL19686042 0.86 KDM4E (0.42) SCN2BSCN1ASCN1BSCN5ASCN9A
SCHEMBL19685827 0.85 SCN2B (0.37) APPSCN2BSCN1ASCN1BSCN5A
SCHEMBL19686144 0.84 KDM4E (0.42) APPSCN2BSCN1ASCN1BSCN5A
SCHEMBL19685738 0.84 MAPK8 (0.35) APPSCN2BSCN1ASCN1BSCN5A
SCHEMBL19685723 0.83 BRD4 (0.36) APPSMN1; SMN2LMNAHTTHPGD
SCHEMBL19686043 0.83 ESR1 (0.40) SCN2BSCN1ASCN1BSCN5ASCN9A
SCHEMBL19686143 0.81 KDM4E (0.43) SCN2BSCN1ASCN1BSCN5ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS APP 2048/4885SCN2B 3140/4885SCN1A 1889/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS APP 2048/4885SCN2B 3140/4885SCN1A 1889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.